Johnson & Johnson pauses Covid vaccine trial as participant becomes ill
Johnson & Johnson pauses Covid vaccine trial as participant becomes ill

Washington (AFP) – Johnson & Johnson said Monday it had temporarily halted its Covid-19 vaccine trial because one of its participants had become sick.”We have temporarily paused further dosing in all our Covid-19 vaccine candidate clinical trials, including the Phase 3 ENSEMBLE trial, due to an unexplained illness in a study participant,” the company said in a statement.The pause means the enrollment system has been closed for the 60,000-patient clinical trial while the independent patient safety committee is convened.J&J said that serious adverse events (SAEs), such as accidents or illnesses,…

Read More

HEDGE accordingly